Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 5
2003 9
2004 10
2005 11
2006 9
2007 17
2008 19
2009 18
2010 20
2011 25
2012 48
2013 59
2014 59
2015 60
2016 67
2017 66
2018 54
2019 87
2020 46
Text availability
Article attribute
Article type
Publication date

Search Results

628 results
Results by year
Filters applied: . Clear all
Page 1
Macrophage polarization and meta-inflammation.
Li C, Xu MM, Wang K, Adler AJ, Vella AT, Zhou B. Li C, et al. Transl Res. 2018 Jan;191:29-44. doi: 10.1016/j.trsl.2017.10.004. Epub 2017 Nov 3. Transl Res. 2018. PMID: 29154757 Free PMC article. Review.
A CRISPR-Cas12a-derived biosensing platform for the highly sensitive detection of diverse small molecules.
Liang M, Li Z, Wang W, Liu J, Liu L, Zhu G, Karthik L, Wang M, Wang KF, Wang Z, Yu J, Shuai Y, Yu J, Zhang L, Yang Z, Li C, Zhang Q, Shi T, Zhou L, Xie F, Dai H, Liu X, Zhang J, Liu G, Zhuo Y, Zhang B, Liu C, Li S, Xia X, Tong Y, Liu Y, Alterovitz G, Tan GY, Zhang LX. Liang M, et al. Among authors: Li Z, Li C, Li S. Nat Commun. 2019 Aug 14;10(1):3672. doi: 10.1038/s41467-019-11648-1. Nat Commun. 2019. PMID: 31413315 Free PMC article.
Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors.
Sun Y, Niu W, Du F, Du C, Li S, Wang J, Li L, Wang F, Hao Y, Li C, Chi Y. Sun Y, et al. Among authors: Li S, Li L, Li C. J Hematol Oncol. 2016 Oct 4;9(1):105. doi: 10.1186/s13045-016-0332-8. J Hematol Oncol. 2016. PMID: 27716285 Free PMC article. Clinical Trial.
Anti-atherogenic effects of CD36-targeted epigallocatechin gallate-loaded nanoparticles.
Zhang J, Nie S, Zu Y, Abbasi M, Cao J, Li C, Wu D, Labib S, Brackee G, Shen CL, Wang S. Zhang J, et al. Among authors: Li C. J Control Release. 2019 Jun 10;303:263-273. doi: 10.1016/j.jconrel.2019.04.018. Epub 2019 Apr 15. J Control Release. 2019. PMID: 30999008 Free PMC article.
Pharmacokinetics and disposition of anlotinib, an oral tyrosine kinase inhibitor, in experimental animal species.
Zhong CC, Chen F, Yang JL, Jia WW, Li L, Cheng C, Du FF, Zhang SP, Xie CY, Zhang NT, Olaleye OE, Wang FQ, Xu F, Lou LG, Chen DY, Niu W, Li C. Zhong CC, et al. Among authors: Li L, Li C. Acta Pharmacol Sin. 2018 Jun;39(6):1048-1063. doi: 10.1038/aps.2017.199. Epub 2018 Apr 5. Acta Pharmacol Sin. 2018. PMID: 29620050 Free PMC article.
628 results
Jump to page
Feedback